Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya

Schistosomiasis Mansoni Clinical Trial

Official title:

Evaluation of Applicability of Urine Based Schistosomiasis Test Strip in the Epidemiologic Mapping and Sampling of Schistosoma Mansoni Infection in Low Endemic Areas of Kenya

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00463307
• Other study ID #: SRP-KY-JK-06
• Status: Completed
• Phase: N/A
• First received: April 19, 2007
• Last updated: October 30, 2007
• Start date: April 2006
• Est. completion date: November 2006

Study information

• Verified date: October 2007
• Source: DBL -Institute for Health Research and Development
• Contact: n/a
• Is FDA regulated: No
• Health authority: Kenya: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to evaluate the use of a urine test strip in diagnose schistosoma mansoni in areas of Kenya where the rate of infections are low.

The hypothesis is that the urine strip test is a superior tool to the conventional parasitological tools used to diagnose schistosomiasis mansoni infections in area where there is low transmission

Description:

The study will compare the use of the urine test strip with the conventional method used and with a "golden standard" methode, in an area of Kenya where the infection transmission is low. Furthermore will the urine test strip be evaluatied in its ability to monitor the intensity of infections in school children before and after they are been treated for the infections.

A total of 1100 school children in the age between 10 and 18 years will be included in the study. Children have to submitt a stool and a urine sample on three consecutive days. Children who are found to be infected with the schistosomiasis parasite will be offered treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1100
• Est. completion date: November 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 10 Years to 18 Years

Eligibility

Inclusion Criteria:

• Children in the age between 10 and 18 years

Exclusion Criteria:

• Children younger then 10 years of age and children whos parent/guardians did not give informed consents for their participation in the study

Study Design

N/A

Related Conditions & MeSH terms

• Circulating Cathodic Antigen Urine Based Dipstick
• Schistosomiasis
• Schistosomiasis mansoni

Locations

Country	Name	City	State
Kenya	Kenya Medical Research Institute	Nairobi

Sponsors (1)

Lead Sponsor	Collaborator
DBL -Institute for Health Research and Development

Country where clinical trial is conducted

Kenya,